1. A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation. Issue 1 (2nd January 2017) Authors: Weisel, Katja; Doyen, Chantal; Dimopoulos, Meletios; Yee, Adrian; Lahuerta, Juan José; Martin, Amber; Travers, Karin; Druyts, Eric; Toor, Kabirraaj; Abildgaard, Niels; Lu, Jin; Van Droogenbroeck, Jan; Geraldes, Catarina; Petrini, Mario; Voillat, Laurent; Voog, Eric; Facon, Thierry Journal: Leukemia & lymphoma Issue: Volume 58:Issue 1(2017) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups. Issue 12 (December 2018) Authors: Bolli, Niccolo; Biancon, Giulia; Moarii, Matahi; Gimondi, Silvia; Li, Yilong; Philippis, Chiara; Maura, Francesco; Sathiaseelan, Vijitha; Tai, Yu-Tzu; Mudie, Laura; O'Meara, Sarah; Raine, Keiran; Teague, Jon; Butler, Adam; Carniti, Cristiana; Gerstung, Moritz; Bagratuni, Tina; Kastritis, Efstathi... Journal: Leukemia Issue: Volume 32:Issue 12(2018) Page Start: 2604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Carfilzomib and dexamethasone versus eight cycles of bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma: an indirect comparison using data from the phase 3 ENDEAVOR and CASTOR trials. Issue 1 (2nd January 2020) Authors: Weisel, Katja; Majer, Istvan; DeCosta, Lucy; Oriol, Albert; Goldschmidt, Hartmut; Ludwig, Heinz; Campioni, Marco; Szabo, Zsolt; Dimopoulos, Meletios Journal: Leukemia & lymphoma Issue: Volume 61:Issue 1(2020) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study. Issue 10245 (18th July 2020) Authors: Dimopoulos, Meletios; Quach, Hang; Mateos, Maria-Victoria; Landgren, Ola; Leleu, Xavier; Siegel, David; Weisel, Katja; Yang, Hui; Klippel, Zandra; Zahlten-Kumeli, Anita; Usmani, Saad Z Journal: Lancet Issue: Volume 396:Issue 10245(2020) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study. Issue 1 (January 2022) Authors: Usmani, Saad Z; Quach, Hang; Mateos, Maria-Victoria; Landgren, Ola; Leleu, Xavier; Siegel, David; Weisel, Katja; Gavriatopoulou, Maria; Oriol, Albert; Rabin, Neil; Nooka, Ajay; Qi, Ming; Beksac, Meral; Jakubowiak, Andrzej; Ding, Bifeng; Zahlten-Kumeli, Anita; Yusuf, Akeem; Dimopoulos, Meletios Journal: Lancet oncology Issue: Volume 23:Issue 1(2022) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies. Issue 12 (December 2018) Authors: Bagratuni, Tina; Ntanasis-Stathopoulos, Ioannis; Gavriatopoulou, Maria; Mavrianou-Koutsoukou, Nefeli; Liacos, Christine; Patseas, Dimitrios; Kanellias, Nikolaos; Migkou, Magdalini; Ziogas, Dimitrios; Eleutherakis-Papaiakovou, Evangelos; Roussou, Maria; Fotiou, Despina; Terpos, Evangelos; Kastriti... Journal: Leukemia Issue: Volume 32:Issue 12(2018) Page Start: 2617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of weekly carfilzomib (70 mg/m2), dexamethasone, and daratumumab (KdD70) is comparable to twice-weekly KdD56 while being a more convenient dosing option: a cross-study comparison of the CANDOR and EQUULEUS studies. Issue 2 (28th January 2021) Authors: Leleu, Xavier; Beksac, Meral; Chou, Takaaki; Dimopoulos, Meletios; Yoon, Sung-Soo; Prince, H. Miles; Pour, Ludek; Shelekhova, Tatiana; Chari, Ajai; Khurana, Monica; Zhang, Jianqi; Obreja, Mihaela; Qi, Ming; Oriol, Albert; Siegel, David Journal: Leukemia & lymphoma Issue: Volume 62:Issue 2(2021) Page Start: 358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. European Perspective on Multiple Myeloma Treatment Strategies in 2014. (25th July 2014) Authors: Ludwig, Heinz; Sonneveld, Pieter; Davies, Faith; Bladé, Joan; Boccadoro, Mario; Cavo, Michele; Morgan, Gareth; de la Rubia, Javier; Delforge, Michel; Dimopoulos, Meletios; Einsele, Hermann; Facon, Thierry; Goldschmidt, Hartmut; Moreau, Philippe; Nahi, Hareth; Plesner, Torben; San-Miguel, Jesús; H... Journal: Oncologist Issue: Volume 19:Number 8(2014) Page Start: 829 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. European Perspective on Multiple Myeloma Treatment Strategies in 2014. (25th July 2014) Authors: Ludwig, Heinz; Sonneveld, Pieter; Davies, Faith; Bladé, Joan; Boccadoro, Mario; Cavo, Michele; Morgan, Gareth; de la Rubia, Javier; Delforge, Michel; Dimopoulos, Meletios; Einsele, Hermann; Facon, Thierry; Goldschmidt, Hartmut; Moreau, Philippe; Nahi, Hareth; Plesner, Torben; San‐Miguel, Jesús; H... Journal: Oncologist Issue: Volume 19:Number 8(2014) Page Start: 829 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma. Issue 8 (2nd July 2020) Authors: Weisel, Katja; Dimopoulos, Meletios; Moreau, Philippe; Yagci, Munci; Larocca, Alessandra; Kanate, Abraham S.; Vural, Filiz; Cascavilla, Nicola; Basu, Supratik; Johnson, Peter; Byeff, Peter; Hus, Marek; Rodríguez-Otero, Paula; Muelduer, Ercan; Anttila, Pekka; Hayden, Patrick J.; Krauth, Maria-Ther... Journal: Leukemia & lymphoma Issue: Volume 61:Issue 8(2020) Page Start: 1850 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗